A £35m proton cancer treatment centre is to be built in Knowledge Quarter Liverpool’s Paddington Village, the £1bn 30-acre development in the university district.
This will be one of four centres built by Proton Partners International in the UK and will make the company the world’s largest developer of proton beam therapy centres.
Operational in 2018 and able to treat up to 700 patients a year, the new facility, to be called the Rutherford Cancer Centre North West, will be based yards from where RCP North, the new northern headquarters of the Royal College of Physicians, will also be built. The announcement comes one week after a double boost for Knowledge Quarter Liverpool, which lies within one of the city’s five Mayoral Development Zones.
Liverpool City Council’s cabinet greenlit the drafting of a gateway masterplan to connect the city centre to KQ Liverpool and the authority’s planning committee approved a 13-storey live-and-learn base for Liverpool International College, also in Paddington Village.
Mayor of Liverpool, Joe Anderson, said: “Momentum is really beginning to build for KQ Liverpool and we can expect more exciting announcements, like Proton Partners International’s, which will further cement its reputation as a world-leading innovation district, specialising in medical and life sciences research.”
Mike Moran, chief executive officer of Proton Partners International, said the deal was the completion of a lifetime ambition after his interest in the non-intrusive therapy was first fuelled by his brother’s cancer diagnosis.
Proton Partners International also shares research interests with the University of Liverpool’s physics department in detector research and through the European network on the Optimisation of Medical Accelerator.
Moran added: “As someone born in Liverpool I’m genuinely thrilled Proton Partners International will be part of this exciting new chapter in the city’s history. To see the centre being located where my brother went to school, and after what he went through, is a story that’s come full circle in many ways.
“I know how important KQ Liverpool is for the city and the entire North of England in creating a site of global significance for the scientific community.
“The Rutherford Cancer Centre North West will not just benefit private patients, but we will also treat patients referred by the NHS in need of more highly specialised cancer care. We are working with global leaders in proton beam therapy – our centres will be equipped with the best technology there is.”
Speaking in Cannes this morning, Moran added: “Our supply chain will come from the local area. We will make a big impact with how we act responsibly as an organisation and the way we work with the city to drive Liverpool’s message.”
As well as the Proton Treatment Centre, KQ Liverpool will be home to the new Clatterbridge Cancer Centre, which last month launched a fundraising campaign to help facilitate its development.
Colin Sinclair, chief executive of KQ Liverpool, is in Cannes as part of Liverpool’s largest delegation at MIPIM, said: “This is further proof that the city region’s offering in health, science and tech truly is world-class.”